Opinions are split about whether the return of one of their own to the White House is helping or hindering the industry.

Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...

"Health insurance premiums are directly tied to the underlying costs of medical care, and as medical costs go up, that’s ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 ...

One of the most authentic and wondrous songwriters of his generation, we've given ourselves the tough job of picking out his ...

The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising ...

It’s just beautiful.” In the months I spoke with Eppinger, he appeared to have a trader’s ability to make friends wherever he ...

In the Phase III results presented and published today, olezarsen demonstrated rapid, substantial and significant reductions in triglycerides by up to 72% on top of standard of care and reduced the ...

Capricor Therapeutics, Inc. ( CAPR) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Third Quarter 2025 Conference ...

Kaiser Permanente Medicare Advantage and FEHB give you seamless care, top doctors, and wellness benefits that fit your life.

A strategic arrangement between Eli Lilly and the U.S. government is set to fundamentally reshape the commercial landscape for blockbuster weight-loss and di ...

Comments by head of Nice come as ministers offer to increase spending to appease pharma groups and Donald Trump ...